We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.63%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$8.03B
AUM Growth
+$623M
Cap. Flow
+$140M
Cap. Flow %
1.74%
Top 10 Hldgs %
21.01%
Holding
374
New
14
Increased
167
Reduced
142
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$32.2M
2
META icon
Meta Platforms (Facebook)
META
+$31.5M
3
COLM icon
Columbia Sportswear
COLM
+$26.9M
4
AKAM icon
Akamai
AKAM
+$24.8M
5
EA icon
Electronic Arts
EA
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 16.06%
3 Industrials 14.43%
4 Financials 12.73%
5 Consumer Discretionary 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMC icon
151
Omnicom Group
OMC
$21.6B
$17M 0.21%
342,916
-20,946
-6% -$1.12M
HP icon
152
Helmerich & Payne
HP
$3.45B
$17M 0.21%
1,158,627
+258,630
+29% +$4.51M
COHR
153
DELISTED
Coherent Inc
COHR
$16.6M 0.21%
149,361
-53,033
-26% -$6.42M
ATRI
154
DELISTED
Atrion Corp
ATRI
$16.5M 0.21%
26,431
+1,131
+4% +$729K
VAR
155
DELISTED
Varian Medical Systems, Inc.
VAR
$16.5M 0.21%
96,029
-365,682
-79% -$57.5M
HSIC icon
156
Henry Schein
HSIC
$9.77B
$16.3M 0.2%
277,901
-33,004
-11% -$2.12M
NDSN icon
157
Nordson
NDSN
$16.6B
$16.1M 0.2%
83,798
+729
+0.9% +$140K
CPT icon
158
Camden Property Trust
CPT
$11B
$16M 0.2%
180,120
+1,889
+1% +$170K
DLB icon
159
Dolby
DLB
$5.56B
$16M 0.2%
241,302
+2,570
+1% +$174K
IDCC icon
160
InterDigital
IDCC
$7.88B
$15.9M 0.2%
277,821
+12,257
+5% +$736K
DHR icon
161
Danaher
DHR
$137B
$15.7M 0.2%
82,021
-29,529
-26% -$5.25M
DOC
162
DELISTED
PHYSICIANS REALTY TRUST
DOC
$15.6M 0.19%
+872,894
New +$15.5M
BRO icon
163
Brown & Brown
BRO
$23.6B
$15.4M 0.19%
340,851
+3,241
+1% +$145K
CBOE icon
164
Cboe Global Markets
CBOE
$32.5B
$15.3M 0.19%
173,931
+26,349
+18% +$2.37M
XOM icon
165
ExxonMobil
XOM
$644B
$14.5M 0.18%
421,819
-16,415
-4% -$671K
CRL icon
166
Charles River Laboratories
CRL
$11.2B
$14.3M 0.18%
63,139
+989
+2% +$205K
SCI icon
167
Service Corp International
SCI
$11.8B
$14.3M 0.18%
338,898
+62,173
+22% +$2.65M
CDK
168
DELISTED
CDK Global, Inc.
CDK
$14.3M 0.18%
327,224
+3,698
+1% +$164K
JNPR
169
DELISTED
Juniper Networks
JNPR
$13.7M 0.17%
638,346
+6,009
+1% +$142K
GDOT icon
170
Green Dot
GDOT
$743M
$13.6M 0.17%
269,285
+12,091
+5% +$620K
ANIK icon
171
Anika Therapeutics
ANIK
$258M
$13.3M 0.17%
375,498
+17,016
+5% +$615K
FHB icon
172
First Hawaiian
FHB
$3.38B
$13.3M 0.17%
916,504
+32,558
+4% +$536K
UTL icon
173
Unitil
UTL
$970M
$13.2M 0.16%
340,488
+119,085
+54% +$5M
HST icon
174
Host Hotels & Resorts
HST
$17.2B
$13.1M 0.16%
1,210,724
+12,758
+1% +$141K
WHD icon
175
Cactus
WHD
$5.21B
$12.9M 0.16%
+670,090
New +$14.5M

Similar funds

Boston Trust Walden's Q3 2020 Portfolio in Review

As of Q3 2020, Boston Trust Walden held 374 positions worth $8.03B, up 8.4% from $7.41B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Trust Walden's Q3 2020 filing shows 14 new, 167 increased, 142 reduced and 11 closed positions. Its largest new stake was Columbia Sportswear: 324,034 shares worth $28.2M. The largest sale was Varian Medical Systems, Inc., an estimated $57.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Trust Walden's largest Q3 2020 buy was Columbia Sportswear: 324,034 shares worth $28.2M.
  • Boston Trust Walden added most to Amgen in Q3 2020, an estimated $32.2M increase.
  • Boston Trust Walden's biggest Q3 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $57.5M.
  • Boston Trust Walden fully exited Highwoods Properties in Q3 2020, selling an estimated $30.7M.
  • Boston Trust Walden's ten largest holdings make up 21% of its $8.03B portfolio in Q3 2020.
  • Boston Trust Walden opened 14 new positions and closed 11 in Q3 2020.
  • Boston Trust Walden's portfolio value rose 8.4% quarter-over-quarter to $8.03B.

Based on Boston Trust Walden's 13F filing for Q3 2020, filed 14 Oct 2020.